NewslettersHuman Immunology News Peptide-Mediated Delivery of CRISPR Enzymes for the Efficient Editing of Primary Human Lymphocytes By Laurisa Dohm - April 25, 2023 0 Scientists showed that the yields of edited primary human lymphocytes could be increased substantially by delivering a CRISPR ribonucleoprotein mixed with an amphiphilic peptide identified through screening. [Nature Biomedical Engineering] Abstract